EUVIMEDEUVIMED entdecken
Open Access

Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs

Rui Feng iD, Yong-Qi Zhen iD, Dongbo Wu iD, Lian Sun iD, Jin-Bu Xu iD, Xiaohuan Li iD, Lan Zhang iD, Feng Gao iD

Science Advances · 2024

DOI: 10.1126/sciadv.adl0026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Rui Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: Palladium, Lung Neoplasms, Acrylamides, Aniline Compounds. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achieving regioselective synthesis in complex molecules with multiple reactive sites remains a tremendous challenge in synthetic chemistry. Regiodivergent palladium-catalyzed C─H arylation of complex antitumor drug osimertinib with various aryl bromides via the late-stage functionalization strategy was demonstrated here. This reaction displayed a switch in regioselectivity under complete base control. Potassium carbonate (K 2 CO 3 ) promoted the arylation of acrylamide terminal C(sp 2 )-H, affording 34 derivatives. Conversely, sodium tert -butoxide ( t -BuONa) mediated the aryl C(sp 2 )-H arylation of the indole C2 position, providing 27 derivatives. The derivative 3r containing a 3-fluorophenyl group at the indole C2 position demonstrated similar inhibition of EGFR T790M/L858R and superior antiproliferative activity in H1975 cells compared to osimertinib, as well as similar antiproliferative activity in A549 cells and antitumor efficacy in xenograft mouse model bearing H1975 cells. This approach provides a “one substrate–multi reactions–multiple products” strategy for the structural modification of complex drug molecules, creating more opportunities for the fast screening of pharmaceutical molecules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PalladiumLung NeoplasmsAcrylamidesAniline CompoundsPyrimidinesHumansAnimalsMiceErbB ReceptorsMutationProtein Kinase InhibitorsIndolesCatalysis

Substanzen

osimertinibPalladiumErbB ReceptorsProtein Kinase InhibitorsIndolesAcrylamidesAniline CompoundsPyrimidines

Autor:innen und Institutionen

  • Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, P.R. China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, P.R. China.
  • Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, P.R. China.

ORCID-Profile: Rui Feng, Yong-Qi Zhen, Dongbo Wu, Lian Sun, Jin-Bu Xu, Xiaohuan Li, Lan Zhang, Feng Gao

Zitieren

APA

Feng, R., Zhen, Y. Q., Wu, D., Sun, L., Xu, J. B., Li, X., Zhang, L., & Gao, F. (2024). Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs. Science Advances. https://doi.org/10.1126/sciadv.adl0026

Vancouver

Feng R, Zhen YQ, Wu D, Sun L, Xu JB, Li X, et al. Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs. Science Advances. 2024. doi:10.1126/sciadv.adl0026

BibTeX
@article{Feng2024,
  author = {Feng, Rui and Zhen, Yong-Qi and Wu, Dongbo and Sun, Lian and Xu, Jin-Bu and Li, Xiaohuan and Zhang, Lan and Gao, Feng},
  title = {Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adl0026}
}
Kostenlos starten →